We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
HCA Healthcare, Inc. (HCA - Free Report) is poised for long-term growth on the back robust organic and inorganic growth, solid capital position and vast business scale.
HCA Healthcare’s growth strategy remains focused on investing in access points in its networks that provide convenience and choice to patients. In 2015, the company began acquiring and developing freestanding emergency rooms and urgent care centers. The company continued with this in 2018. Going forward, the company will continue to invest in market brands to better coordinate services between these diverse points of care, which should pave way for long-term growth.
In addition to hospital acquisitions, HCA Healthcare’s multi-year investments in medical technologies like PatientKeeper, iMobile and vitals monitoring devices, have moved out of their pilot phases and are now being deployed company-wide. The company is working to harness the power of big data to efficiently test methodologies, discover trends and provide information to support its physicians and clinicians, which in turn should improve the quality of care to patients.
HCA Healthcare’s investments in information technology make it stand out in the hospital industry and among other players such as Community Health Systems, Inc. (CYH - Free Report) , Tenet Healthcare Corporation (THC - Free Report) and Universal Health Services, Inc. (UHS - Free Report) and more.
Expanding services and hiring physicians remain the primary growth drivers for HCA Healthcare. The quality of physicians employed by the company has improved patient volumes. The company’s continued effort in this arena should drive up volumes, consequently bolstering revenues.
Further, strong cash flow generation by the company enables it to pursue accretive mergers and acquisitions in its targeted markets, while executing consistent share repurchase program and dividend payout.
Moreover, capital expenditure investment (carried on for about last two to three years and will continue for the next three years) is a key component of HCA Healthcare’s growth strategy. It is likely to translate into accelerating, above-average same store volume and revenue growth, thereby leading to margin expansion.
Nevertheless, ongoing shift of patients from costly inpatient facilities to low-cost outpatient facilities, home healthcare and the likes will have an effect of depressing patient admission volumes.
Increase in labor cost and shortage of nurses should be a pain and will drive salaries and benefits up, consequently raising operating cost.
Zacks' Top 10 Stocks for 2019
In addition to the stocks discussed above, wouldn't you like to know about our 10 finest buy-and-holds for the year?
From more than 4,000 companies covered by the Zacks Rank, these 10 were picked by a process that consistently beats the market. Even during 2018 while the market dropped -5.2%, our Top 10s were up well into double-digits. And during bullish 2012 – 2017, they soared far above the market's +126.3%, reaching +181.9%.
This year, the portfolio features a player that thrives on volatility, an AI comer, and a dynamic tech company that helps doctors deliver better patient outcomes at lower costs.
Image: Bigstock
HCA Healthcare's Organic & Inorganic Strategies Drive Growth
Zacks' Top 10 Stocks for 2019
In addition to the stocks discussed above, wouldn't you like to know about our 10 finest buy-and-holds for the year?
From more than 4,000 companies covered by the Zacks Rank, these 10 were picked by a process that consistently beats the market. Even during 2018 while the market dropped -5.2%, our Top 10s were up well into double-digits. And during bullish 2012 – 2017, they soared far above the market's +126.3%, reaching +181.9%.
This year, the portfolio features a player that thrives on volatility, an AI comer, and a dynamic tech company that helps doctors deliver better patient outcomes at lower costs.
See Stocks Today >>